Jean-Pierre Sommadossi
CEO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Atea Pharmaceuticals, Inc. (AVIR) | President, Chief Executive Officer and Chairman of the Board | $703,490 | $3,403,752 |
| 2024 | Atea Pharmaceuticals, Inc. (AVIR) | President, Chief Executive Officer and Chairman of the Board | $703,490 | $4,202,323 |
| 2023 | Atea Pharmaceuticals, Inc. (AVIR) | President, Chief Executive Officer and Chairman of the Board | $683,000 | $5,925,790 |
| 2022 | Atea Pharmaceuticals, Inc. (AVIR) | President, Chief Executive Officer and Chairman of the Board | $650,000 | $5,878,026 |
| 2021 | Atea Pharmaceuticals, Inc. (AVIR) | President, Chief Executive Officer and Chairman of the Board | $650,000 | $34,104,892 |
| 2020 | Atea Pharmaceuticals, Inc. (AVIR) | President, Chief Executive Officer and Chairman of the Board | $436,862 | $2,886,987 |
| 2019 | Atea Pharmaceuticals, Inc. (AVIR) | President, Chief Executive Officer and Chairman of the Board | $400,000 | $811,080 |
Executive changes
Earnings-call appearances
-
Atea Pharmaceuticals, Inc. Q1 FY2026 Earnings Call2026-05-12
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q4 FY2025 Earnings Call2026-03-05
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q3 FY2025 Earnings Call2025-11-12
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q2 FY2025 Earnings Call2025-08-07
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q4 FY2024 Earnings Call2025-01-14
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q3 FY2024 Earnings Call2024-11-07
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q2 FY2024 Earnings Call2024-08-07
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q1 FY2024 Earnings Call2024-05-14
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q4 FY2023 Earnings Call2024-02-28
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q3 FY2023 Earnings Call2023-11-08
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q2 FY2023 Earnings Call2023-08-08
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q1 FY2023 Earnings Call2023-05-08
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q4 FY2022 Earnings Call2023-02-28
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q3 FY2022 Earnings Call2022-11-07
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q2 FY2022 Earnings Call2022-08-08
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q1 FY2022 Earnings Call2022-05-10
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q4 FY2021 Earnings Call2022-02-28
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q3 FY2021 Earnings Call2021-11-12
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q2 FY2021 Earnings Call2021-08-12
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q1 FY2021 Earnings Call2021-05-13
Atea Pharmaceuticals, Inc. (AVIR)